Zoekresultaten - 161 results
Influenza versus other respiratory viruses – assessing severity among hospitalised children, Belgium, 2011 to 2020.
Volume 28, Issue 29 (2023) Health Topics: Influenza Influenza Influenza Manuscript versions: DOI: https://doi.org/10.2807/1560-7917.ES.2023.28.29.2300056 File: Version: Published Full text access: ...
Bulletin acute luchtweginfecties week 48-2024- Gepubliceerd op 04.12.2024
syncytial virus (RSV) RSV SARI surveillance SARS-CoV-2 Health Topics: Acute respiratory tract infection Acute luchtweginfectie Infection respiratoire aiguë Influenza Influenza Influenza Coronavirus ...
Bulletin infections respiratoires aiguës semaine 48-2024- Publié 04/12/24
Coronavirus Grippe infection respiratoire aiguë INFLUENZA respiratoires SARI surveillance SARS-CoV-2 virus respiratoire syncytial VRS Health Topics: Influenza Influenza Influenza Acute respiratory tract ...
Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken.
of recombinant herpesvirus of turkey, expressing the H9 hemagglutinin gene from low pathogenic avian influenza virus (LPAIV) H9N2 and the avian orthoavulavirus-1 (AOAV-1) (commonly known as Newcastle ...
Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024.
COVID-19 Europe Humans Influenza, Human Respiratory Syncytial Virus Infections Respiratory Syncytial Virus, Human Seasons Abstract: Since the end of November 2023, the European Mortality Monitoring Network ...
Protection conferred by an H5 DNA vaccine against highly pathogenic avian influenza in chickens: The effect of vaccination schedules.
highly pathogenic avian influenza (HPAI) viruses of the Asian lineage (A/goose/Guangdong/1/96) belonging to clade 2.3.4.4 have spread worldwide through wild bird migration in two major waves: in 2014/2015 ...
Regulatory workshop on challenge strain development and GMP manufacture- A stakeholder meeting report.
Influenza Vaccines Influenza, Human Viruses Abstract: Within the Innovative Health Initiative (IHI) Inno4Vac CHIMICHURRI project, a regulatory workshop was organised on the development and manufacture of ...
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
SARI Surveillance Network (BelsariNet) Source: Influenza Other Respir Viruses, Volume 18, Issue 2 (2024) Keywords: Adult Case-Control Studies Europe Hospitalization hospitals Humans Influenza A Virus ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Anthony; Nicolay, Nathalie; Monge, Susana; VEBIS-Lot4 working group Source: Influenza Other Respir Viruses, Volume 17, Issue 11 (2023) Keywords: Aged COVID-19 COVID-19 Vaccines Electronics Hospitalization ...
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Paula; Bennett, Charlene; Domegan, Lisa; Kalaveshi, Arijana; Jakupi, Xhevat; Ovliyakulova, Gurbangul; Korsun, Neli; Vladimirova, Nadezhda Source: Influenza Other Respir Viruses, Volume 17, Issue 11 (2023) ...